A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
about
From DCPD to NTCP: the long journey towards identifying a functional hepatitis B virus receptorHuman immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionCell Culture Models for the Investigation of Hepatitis B and D Virus InfectionElucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsuleStable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B VirusInhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesModification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathwaysHuman coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cellsProteoglycans act as cellular hepatitis delta virus attachment receptors.Hepatitis B virus large surface protein: function and fame.Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting PolypeptideHepatitis B virus efficiently infects non-adherent hepatoma cells via human sodium taurocholate cotransporting polypeptideOverview of hepatitis B viral replication and genetic variabilitySodium taurocholate cotransporting polypeptide mediates woolly monkey hepatitis B virus infection of Tupaia hepatocytes.Progress With Developing Use of Gene Editing To Cure Chronic Infection With Hepatitis B Virus.Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptideMedical virology of hepatitis B: how it began and where we are nowA human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect.Unusual Features of Sodium Taurocholate Cotransporting Polypeptide as a Hepatitis B Virus Receptor.A novel toolbox for the in vitro assay of hepatitis D virus infection.Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.Suramin interacts with the positively charged region surrounding the 5-fold axis of the EV-A71 capsid and inhibits multiple enterovirus A.Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.Early events in hepatitis B virus infection: From the cell surface to the nucleus.Viral life cycle of hepatitis B virus: Host factors and druggable targets.Hepatitis B virus receptors and molecular drug targets.Enhanced humanization and affinity maturation of neutralizing anti-hepatitis B virus preS1 antibody based on antigen-antibody complex structure.Activating the innate immune response to counter chronic hepatitis B virus infection.Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment.Hepatitis Delta Virus: Replication Strategy and Upcoming Therapeutic Options for a Neglected Human Pathogen.Antibody-mediated immunotherapy against chronic hepatitis B virus infection.Live Cell Imaging Confocal Microscopy Analysis of HBV Myr-PreS1 Peptide Binding and Uptake in NTCP-GFP Expressing HepG2 Cells.Characterization of hepatitis B virus surface antigen variability and impact on HBs antigen clearance under nucleos(t)ide analogue therapy.A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal.A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.Recent advances in managing hepatitis DThe Structural Biology of Hepatitis B Virus: Form and Function.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.
P2860
Q26777485-EB99ACAC-73A4-479F-8FF3-F624414E3B5EQ27004059-1402B8A5-9C32-4267-A5DF-EEEB6195A71DQ28068209-06E5A383-9181-4E09-848E-9D9B3E5CFF75Q28070320-B4B4617F-F070-4F32-8C99-86A396153732Q28551711-56FF5D28-57E5-4A42-B8C1-10C5074CB83AQ33821878-32112A28-F898-490C-94DA-66979B1B60BFQ34059278-8AF6DF3F-93B6-43B8-BC01-E142A097D9B8Q34137297-0212E6EB-1EA7-417A-B8DC-BF14BBE0C090Q34594739-1F62D168-9F98-4C0F-AC34-C10EF6622014Q34625734-975C23D2-0AD2-4923-A575-1183AB949798Q35055364-2DA421EE-4EA7-4E70-9BE4-1660F13D4E01Q35526264-BD447A01-9D7F-44CF-A5FC-F826C06644D3Q36305699-7B801CE7-0392-4A1E-95B6-254A43E08D7EQ36807341-78CF8EFC-7660-4E74-B862-5BBD5516DB44Q36911797-F2C74172-C9A1-4E28-B145-EC1DAF5C1C1DQ36951290-5563B968-D033-4770-8FDE-9614A44CD59CQ36978561-EB3DE6DC-759C-4551-8585-EA33F8A3A542Q37059714-B319B84F-1D31-41FB-93E1-188244FFD813Q37138946-0A016B1E-2BBD-444A-9FD8-A21153DE48F5Q37224888-29B18592-2C31-43FA-ACB5-36CE62248460Q37581726-407C4D45-F618-41DC-AFE0-D4DBCC90EAE7Q37643774-42D70972-A8D0-4897-A3CF-4958B57F0D91Q37652678-4ADA08AC-55C1-40E6-A138-0860EA9B7A38Q38293584-2D563390-91D3-4451-80C6-6186BC60DF15Q38560069-AE9ABB91-C24B-4919-A1C5-ED15A524101BQ38594482-4D468F27-B050-435D-A557-22676C5496F4Q38699649-804D74FD-00C0-4568-8872-CA2D33B27067Q38775846-78EDB154-932A-4C2F-A722-3BC39B4637D4Q38931731-784028B3-5E6E-4144-9878-199C1797A1B7Q38948529-CB1E30DD-A1E0-46CD-A4CA-EF52FF708492Q39174473-CC9217AF-48C6-4211-8D67-47DDB99903EDQ39414876-26687E83-1838-4460-9E57-49E9C410AFD9Q40196246-F93B4DB4-E607-4D81-81BC-3DC91A280BF8Q40409397-C796BB39-A3E8-4DF3-A024-7455ED764281Q40841454-DD7753FF-EE54-46DB-B36F-593E9679DA40Q40893286-7C44EADF-DBD9-46E5-9BBE-7CE2517D01CFQ41082130-574152F4-2579-4E1A-BBAA-B746C5D3AEA4Q41588940-18889842-F962-4F54-9759-0589A6FE9754Q42048428-ACA3656D-6B81-44A0-8B96-8DF522C6859EQ45323707-391D71B8-8555-4BA8-A99C-2EA72C6AA4E5
P2860
A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A conformational heparan sulfa ...... patitis B virus a-determinant.
@en
A conformational heparan sulfa ...... patitis B virus a-determinant.
@nl
type
label
A conformational heparan sulfa ...... patitis B virus a-determinant.
@en
A conformational heparan sulfa ...... patitis B virus a-determinant.
@nl
prefLabel
A conformational heparan sulfa ...... patitis B virus a-determinant.
@en
A conformational heparan sulfa ...... patitis B virus a-determinant.
@nl
P2860
P356
P1433
P1476
A conformational heparan sulfa ...... patitis B virus a-determinant.
@en
P2093
Camille Sureau
Jessica Salisse
P2860
P304
P356
10.1002/HEP.26125
P407
P577
2013-02-15T00:00:00Z